PS-110-Ketohexokinase inhibitor PF-06835919 administered for 6 weeks reduces whole liver fat as measured by magnetic resonance imaging-proton density fat fraction in subjects with non-alcoholic fatty liver disease

Details 詳細情報について

• CRID

  1361418520284323456

• DOI

  10.1016/s0618-8278(19)30122-7

• ISSN

  01688278

• Web Site

  https://api.elsevier.com/content/article/PII:S0618827819301227?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0618827819301227?httpAccept=text/plain

• Data Source

  • Crossref